Riparian Pharmaceuticals
2012
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$500K
LATEST DEAL AMOUNT
9
INVESTORS
Description
Developer of a medical therapy designed to treat cardiovascular and inflammatory diseases. The company's therapy helps physicians to treat cardiovascular diseases, reduce vascular inflammation and reverse endothelial dysfunction, enabling them to treat patients effectively.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
- 127 Western Avenue
- Boston, MA 02134
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Riparian Pharmaceuticals’s full profile, request a free trial.
Riparian Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC (Series A) | 12-Oct-2018 | $500K | 00000 | 00.00 | Completed | Startup |
| 8. Accelerator/Incubator | 05-Oct-2017 | Completed | Startup | |||
| 7. Accelerator/Incubator | 13-Oct-2016 | Completed | Startup | |||
| 6. Accelerator/Incubator | Completed | Startup | ||||
| 5. Grant | 06-Jun-2016 | 00000 | Completed | Startup | ||
| 4. Grant | 01-Jan-2016 | 00.000 | Completed | Startup | ||
| 3. Grant | 01-Jan-2016 | 00000 | Completed | Startup | ||
| 2. Grant | 16-Oct-2015 | $200K | Completed | Startup | ||
| 1. Grant | 01-Jan-2013 | $857K | Completed | Startup |
Riparian Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Riparian Pharmaceuticals Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| JMCR Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Sprout Bioventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Harvard Innovation Launch Lab | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| Pagliuca Harvard Life Lab | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| Janssen Research and Development | Corporation | 000 0000 | 000000 0 |
Riparian Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| William Adams Ph.D | Co-Founder, President, Chief Executive Officer & Board Member | ||
| Guillermo Garcia-Cardena Ph.D | Co-Founder & Scientific Advisor |
Riparian Pharmaceuticals Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Michael Serrano-Wu | Riparian Pharmaceuticals | Board Member | 000 0000 | |
| William Adams Ph.D | Riparian Pharmaceuticals | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 |